Status: Not yet recruiting
BCAAs in Concussion 3.0
This study is a randomized, placebo-controlled, double-blinded, therapeutic exploratory clinical trial of branched chain amino acids (BCAAs) in the treatment of concussion. The aim of the study is to determine whether administration of high-dose BCAAs compared to placebo promotes concussion recovery.
Participants needed: 150
Trial details
Phase: Phase 2Age: 11-23Biological sex: AllType: InterventionalSponsor: Akiva CohenUpdated: Jun 26, 2026
Eligibility criteria
Males and females,11 - 23 years of age. [+5]
Evidence of moderate or severe TBI, including GCS <13, TBI requiring hospital ad... [+5]